Sotagliflozin as Prevention of Anthracycline-Related Cardiotoxicity

NCT07572175 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Anthracycline-induced Cardiotoxicity
Lymphoma
Chemotherapy
Cardiotoxicity

Interventions

DRUG: Sotagliflozin
DRUG: Placebo

Sponsor

Icahn School of Medicine at Mount Sinai

Collaborators

[object Object]